Search

everythinglearnresearchcommunity

for

Search:↓

Two different mutations in the vitamin D receptor gene cause different symptoms and responses to treatment in Lebanese patients with hereditary rickets.

The SNP rs6457452 is linked to a higher risk of alopecia areata in Koreans.

Researchers found a new area on chromosome 2 linked to a genetic hair loss condition.

There is a significant need for better-validated quality of life tools in dermatology.

The DLQI is reliable but may not fully capture the impact of skin conditions on quality of life, especially in emotional and psychological areas.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

H1 increases risk for neurodegenerative diseases, while H2 offers protection but is linked to other disorders.

The A allele of the C2 gene increases the risk of lupus, while the G allele may protect against it.

A specific gene mutation causes sparse, brittle hair in a family.

A specific gene variant may increase the risk of developing Alopecia Areata.

A new DSG4 gene mutation causes hair defects in a young girl.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Genetic marker rs12558842 strongly linked to male hair loss.

A specific gene variant (rs4833095) is linked to a higher risk of alopecia areata in Koreans.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Crash dieting can cause hair loss due to severe calorie restriction.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

CD2 might be a new treatment target for patchy alopecia areata.

BTNL2 helps protect hair follicles from immune attacks.

Human hair keratin genes hHa2 and hHb1 are located on chromosomes 17 and 12.

Mutations in the hHb6 gene cause the hair disorder monilethrix.

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.